Use of FDG-PET in the Differential Diagnosis of a Single Bone Lesion in Ovarian Cancer

Clinical Nuclear Medicine

Volumn 29, Issue 3, 2004, Pages 204-205

  Leitha, Thomas ^a   Cesnik, Robert ^a   Steiner, Erich ^b   Frühwald, Franz ^b  

^a DANUBE HOSPITAL   (Austria)

^b Inst F S Obermayer St Polten   (Austria)

Author keywords

Bone metastasis; F 18 fluorodeoxyglucose; Ovarian cancer

Indexed keywords

ETIDRONIC ACID TC 99M; FLUORODEOXYGLUCOSE F 18;

ADULT; ARTICLE; BONE METASTASIS; BONE SCINTISCANNING; CANCER REGRESSION; CASE REPORT; DIFFERENTIAL DIAGNOSIS; FEMALE; HISTOPATHOLOGY; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOPENIA; OVARY CANCER; PATHOLOGIC FRACTURE; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

BONE NEOPLASMS; DIAGNOSIS, DIFFERENTIAL; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; OVARIAN NEOPLASMS; PELVIC BONES; PELVIC NEOPLASMS; RADIOPHARMACEUTICALS; TECHNETIUM TC 99M MEDRONATE;

EID: 1542287450     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.rlu.0000114532.37432.f1     Document Type: Article

References (9)

1. Bohdiewicz PJ, Scott GC, Juni JE, et al. Indium-111 OncoScint CR/OV and F-18 FDG in colorectal and ovarian carcinoma recurrences. Early observations. Clin Nucl Med. 1995;20:230-236.
2. Dehdashti F, Siegel BA, Griffeth LK, et al. Benign versus malignant intraosseous lesions: discrimination by means of PET with 2-[F-18]fluoro-2-deoxy-D-glucose. Radiology. 1996;200:243-247.
3. Puig S, Staudenherz A, Steiner B, et al. Differential diagnosis of atypically located single or double hot spots in whole bone scanning. J Nucl Med. 1998;39:1263-1266.
4. Ohta M, Tokuda Y, Suzuki Y, et al. Whole body PET for the evaluation of bony metastases in patients with breast cancer: comparison with 99Tcm-MDP bone scintigraphy. Nucl Med Commun. 2001;22:875-879.
5. Aoki J, Watanabe H, Shinozaki T, et al. FDG PET of primary benign and malignant bone tumors: standardized uptake value in 52 lesions. Radiology. 2001;219:774-777.
6. Schmitz A, Risse JH, Textor J, et al. FDG-PET findings of vertebral compression fractures in osteoporosis: preliminary results. Osteoporos Int. 2002;13:755-761.
7. Dimitrakopoulou-Strauss A, Strauss LG, Heichel T, et al. The role of quantitative (18)F-FDG PET studies for the differentiation of malignant and benign bone lesions. J Nucl Med. 2002;43:510-518.
8. Kato K, Aoki J, Endo K. Utility of FDG-PET in differential diagnosis of benign and malignant fractures in acute to subacute phase. Ann Nucl Med. 2003;17:41-46.
9. Shon IH, Fogelman I. F-18 FDG positron emission tomography and benign fractures. Clin Nucl Med. 2003;28:171-175.